Winning the war against cancer represents a major goal currently. During the last few years, we have witnessed a fundamental increase in basic knowledge in the biochemical and molecular biological fields connected to oncology, progressively unveiling more precise and selective cancer-related mechanisms and targets to be exploited. Meanwhile, the research and development spending for pharmaceuticals increased by almost an order of magnitude [1]. Even admitting the substantial steps forward thus far made, the rate of cancer death has not decreased accordingly and remains unacceptably high [2]. Hence, the need for novel anticancer strategies directed towards yet unexplored/poorly explored targets. The Special Issue, entitled “Selective Ligands for Non-canonical DNA Structures: Do They Have a Future in Medicinal Chemistry?”, aimed to examine the therapeutic opportunities and drawbacks exhibited by ligands designed to selectively bind non-canonical nucleic acid structures, such as G-quadruplexes (G4) and highly polymorphic guanine-rich structures, participating in telomere protection, gene expression regulation, and genomic instability induction [3,4].

Selective Ligands for Non-Canonical DNA Structures: Do They Have a Future in Medicinal Chemistry?

Sissi, Claudia
2022

Abstract

Winning the war against cancer represents a major goal currently. During the last few years, we have witnessed a fundamental increase in basic knowledge in the biochemical and molecular biological fields connected to oncology, progressively unveiling more precise and selective cancer-related mechanisms and targets to be exploited. Meanwhile, the research and development spending for pharmaceuticals increased by almost an order of magnitude [1]. Even admitting the substantial steps forward thus far made, the rate of cancer death has not decreased accordingly and remains unacceptably high [2]. Hence, the need for novel anticancer strategies directed towards yet unexplored/poorly explored targets. The Special Issue, entitled “Selective Ligands for Non-canonical DNA Structures: Do They Have a Future in Medicinal Chemistry?”, aimed to examine the therapeutic opportunities and drawbacks exhibited by ligands designed to selectively bind non-canonical nucleic acid structures, such as G-quadruplexes (G4) and highly polymorphic guanine-rich structures, participating in telomere protection, gene expression regulation, and genomic instability induction [3,4].
File in questo prodotto:
File Dimensione Formato  
ijms-23-11984.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 204 kB
Formato Adobe PDF
204 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3470578
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact